Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,483
Closed -$841K 95
2022
Q1
$1.99M Sell
9,483
-9,973
-51% -$786K 0.15% 63
2021
Q4
$5.03M Buy
+19,456
New +$1.55M 0.32% 64
2019
Q1
Sell
-47,998
Closed -$3.53M 58
2018
Q4
$3.53M Sell
47,998
-106,896
-69% -$7.55M 1.91% 14
2018
Q3
$10.6M Buy
+154,894
New +$9.87M 4.63% 7

Other funds holding MRK

Eversept Partners's MRK Position: Q2 2022 in Review

Eversept Partners sold out of Merck (MRK) in Q2 2022, closing a stake of 9,483 shares — an estimated $841K sold.

Eversept Partners first reported a position in MRK in Q3 2018 and held it in 4 quarters. The position peaked at $10.6M in Q3 2018. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Eversept Partners reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Eversept Partners sold 9,483 Merck shares in Q2 2022, an estimated $841K.
  • Eversept Partners first reported a position in Merck in Q3 2018 and held it in 4 quarters.
  • Eversept Partners's Merck position peaked at $10.6M in Q3 2018.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.